Takeaway
-
Single-dose AS01 E -adjuvanted RSV prefusion F protein-based vaccine (RSVPreF3 OA) candidate is highly effective against respiratory syncytial virus (RSV)-related lower respiratory tract infection and severe disease in one season among adults aged 60 years and older,...